AzTrials
AzTrials

Infertility, SubfertilityNCT03860636

The Accuracy of Endometrial Ultrasound to Predict Implantation

An observational study of Infertility, Subfertility, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To measure the accuracy of different ultrasound endometrial patterns to predict successful embryo implantation during assisted conception; in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Infertility, Subfertility
What is being tested?
Endometrial Pattern on Ultrasound at ET, Endometrial Pattern on Ultrasound at HCG and Endometrial Pattern on Ultrasound at TVOR
How many people
155 participants
Where
1 siteUnited Kingdom
Study dates
26 Nov 2018to 13 Apr 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Women who are having in vitro fertilisation or intracytoplasmic sperm injection where a clear image of endometrial pattern can be obtained. In cases where we can't obtain a clear endometrial pattern due to pathology or uterine position, we will exclude these cases from analysis. In cases of failure of fertilisation where no embryo is available for transfer these cases will be excluded from analysis.

Who may be able to join

  • Female undergoing in vitro fertilisation or intracytoplasmic sperm injection (IVF/ICSI)
  • Own or donated eggs
  • Informed consent

Who cannot join

  • Known pathology affecting the endometrial cavity (polyp, submucosal fibroid)
  • Septate uterus or more complex uterine abnormality.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Nurture Fertility

    Nottingham, Nottinghamshire, NG10 5QG

Other trials in United Kingdom

About this study

Official title: The Prognostic Accuracy of Within Cycle, Pre-embryo Transfer, Ultrasound Endometrial Patterns, to Predict Implantation During Assisted Reproduction

To measure the accuracy of different ultrasound endometrial patterns to predict successful embryo implantation during assisted conception; in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI).

Read the detailed description

Ultrasound appearance of the endometrium may predict successful implantation in assisted conception, but studies have yielded conflicting results.

The explanation may be different timing of, and classification systems for, the scan, different treatment protocols, and different definitions of success. Also scan quality has improved over time.

This is a prospective study looking at the endometrial pattern as a predictor of IVF/ICSI outcome, adjusting for embryo quality, ease of transfer, and fresh or frozen cycles. The study will focus on good quality single embryo transfer at the blastocyst stage. Other endometrial ultrasound parameters such as thickness, volume and Doppler will also be measured. Reliability studies will also be conducted to assess and account for inter- and intra-observer variation.

200 women will be recruited. They will include approximately 100 undergoing fresh and 100 undergoing frozen embryo transfer. There will be no change to routine clinical care. A single operator will analyse all ultrasound images to reduce inter-observer variation. When there is uncertainty about the pattern the chief investigator will be consulted to reach an agreement.

Being tested
Endometrial Pattern on Ultrasound at ET, Endometrial Pattern on Ultrasound at HCG, Endometrial Pattern on Ultrasound at TVOR, Endometrial Pattern on Ultrasound at co-ordination scan, Endometrial thickness at HCG
Keywords
In Vitro Fertilisation (IVF), Intra Cytoplasmic Injection (ICSI), Endometrial Pattern, Ultrasound
Medical subject headings
Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endometrial Pattern on Ultrasound at ETDiagnostic test

    Ultrasound scan

  • Endometrial Pattern on Ultrasound at HCGDiagnostic test

    Ultrasound

  • Endometrial Pattern on Ultrasound at TVORDiagnostic test

    Ultrasound

  • Endometrial Pattern on Ultrasound at co-ordination scanDiagnostic test

    Ultrasound

  • Endometrial thickness at HCGDiagnostic test

    Ultrasound

  • Endometrial thickness at TVORDiagnostic test

    Ultrasound

  • Endometrial thickness at ETDiagnostic test

    Ultrasound scan

  • Endometrial thickness at coordination scanDiagnostic test

    Ultrasound scan

  • Endometrial volume at HCGDiagnostic test

    Ultrasound scan

  • Endometrial volume at TVORDiagnostic test

    Ultrasound scan

  • Endometrial volume at ETDiagnostic test

    Ultrasound scan

  • Endometrial volume at coordination scanDiagnostic test

    Ultrasound scan

  • Blood test for progesterone at HCGDiagnostic test

    Blood test

  • Blood test for progesterone at TVORDiagnostic test

    Blood test

  • Blood test for progesterone at ETDiagnostic test

    Blood test

  • Blood test for progesterone at coordination scanDiagnostic test

    Blood test

  • Change in endometrial pattern between TVOR and ETDiagnostic test

    Ultrasound scan

  • Blood test for estradiol at HCGDiagnostic test

    Blood test

  • Blood test for estradiol at TVORDiagnostic test

    Blood test

  • Blood test for estradiol at ETDiagnostic test

    Blood test

  • Blood test for estradiol at coordination scanDiagnostic test

    Blood test

  • Endometrial blood flow (doppler) at HCGDiagnostic test

    Ultrasound scan

  • Endometrial blood flow (doppler) at TVORDiagnostic test

    Ultrasound scan

  • Endometrial blood flow (doppler) at ETDiagnostic test

    Ultrasound scan

  • Endometrial blood flow (doppler) at coordination scanDiagnostic test

    Ultrasound scan

  • Contractility at embryo transfer on a subgroup of participantsDiagnostic test

    Ultrasound scan

  • Change in endometrial pattern between coordination scan and ETDiagnostic test

    Ultrasound scan

  • Change in endometrial pattern between HCG and ETDiagnostic test

    Ultrasound scan

Study groups in NCT03860636
Study groupRoleWhat they receive
Fresh Embryo TransferWomen will be invited to attend and have transvaginal ultrasound scans (TVUS) and blood tests at three different points during their treatments. * The day they receive their HCG trigger, * The day of transvaginal oocyte retrieval (TVOR) and * The day of embryo transfer (ET).
Receives: Diagnostic Test: Endometrial Pattern on Ultrasound at ET; Diagnostic Test: Endometrial Pattern on Ultrasound at HCG; Diagnostic Test: Endometrial Pattern on Ultrasound at TVOR; Diagnostic Test: Endometrial thickness at HCG; Diagnostic Test: Endometrial thickness at TVOR; Diagnostic Test: Endometrial thickness at ET; Diagnostic Test: Endometrial volume at HCG; Diagnostic Test: Endometrial volume at TVOR; Diagnostic Test: Endometrial volume at ET; Diagnostic Test: Blood test for progesterone at HCG; Diagnostic Test: Blood test for progesterone at TVOR; Diagnostic Test: Blood test for progesterone at ET; Diagnostic Test: Blood test for estradiol at HCG; Diagnostic Test: Blood test for estradiol at TVOR; Diagnostic Test: Blood test for estradiol at ET; Diagnostic Test: Endometrial blood flow (doppler) at HCG; Diagnostic Test: Endometrial blood flow (doppler) at TVOR; Diagnostic Test: Endometrial blood flow (doppler) at ET; Diagnostic Test: Contractility at embryo transfer on a subgroup of participants; Diagnostic Test: Change in endometrial pattern between HCG and ET
Frozen Embryo TransferWomen will be invited to attend and have transvaginal ultrasound scans (TVUS) and blood tests at two different points during their treatments. * The day we coordinate with embryologist (day of progesterone +/-1) * The day of embryo transfer (ET).
Receives: Diagnostic Test: Endometrial Pattern on Ultrasound at ET; Diagnostic Test: Endometrial Pattern on Ultrasound at co-ordination scan; Diagnostic Test: Endometrial thickness at ET; Diagnostic Test: Endometrial thickness at coordination scan; Diagnostic Test: Endometrial volume at ET; Diagnostic Test: Endometrial volume at coordination scan; Diagnostic Test: Blood test for progesterone at ET; Diagnostic Test: Blood test for progesterone at coordination scan; Diagnostic Test: Change in endometrial pattern between TVOR and ET; Diagnostic Test: Blood test for estradiol at ET; Diagnostic Test: Blood test for estradiol at coordination scan; Diagnostic Test: Endometrial blood flow (doppler) at ET; Diagnostic Test: Endometrial blood flow (doppler) at coordination scan; Diagnostic Test: Contractility at embryo transfer on a subgroup of participants; Diagnostic Test: Change in endometrial pattern between coordination scan and ET

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of clinical pregnancies

    Intrauterine pregnancy with fetal heart detected on ultrasound arising from the treatment cycle

    Measured: Within 12 weeks after embryo transfer (usually scan performed at 6-7 weeks gestation)

Secondary outcomes (4)
  1. Number of ectopic pregnancies

    Ectopic pregnancy resulting from the treatment cycle

    Measured: Within 10 weeks after embryo transfer

  2. Number of biochemical pregnancies

    Biochemical pregnancy resulting from the treatment cycle

    Measured: Within 6 weeks after embryo tranfer

  3. Number of miscarriages

    Miscarriage resulting from the treatment cycle

    Measured: Within 12 weeks after embryo transfer

  4. Number of live birth

    Live birth resulting from the treatment cycle

    Measured: Within one year after embryo transfer

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2019
  2. Study start26 Nov 2018
  3. Primary completion28 Feb 2022
  4. Study completion13 Apr 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
155 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03860636
Sponsor's protocol ID
REC 87-1808
Status last verified
Mar 2025
First submitted
2 Nov 2018
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Infertility, Subfertility, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of clinical pregnancies (time frame: Within 12 weeks after embryo transfer (usually scan performed at 6-7 weeks gestation)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in